Biologic and Immunologic Effects of Preoperative Trastuzumab for Ductal Carcinoma in Situ of the Breast

類似資料

• Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
  著者:: Dominici, Laura S., 等
  出版事項: (2010)
• Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision
  著者:: Yi, Min, 等
  出版事項: (2012)
• Role of Primary Tumor Characteristics in Predicting Positive Sentinel Lymph Nodes in Patients with Ductal Carcinoma in situ or Microinvasive Breast Cancer
  著者:: Yi, Min, 等
  出版事項: (2008)
• Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
  著者:: Kuerer, Henry M., 等
  出版事項: (2012)
• Loss of HER2 Amplification Following Trastuzumab-based Neoadjuvant Systemic Therapy and Survival Outcomes
  著者:: Mittendorf, Elizabeth A., 等
  出版事項: (2009)